Picture of Arix Bioscience logo

ARIX Arix Bioscience News Story

0.000.00%
gb flag iconLast trade - 00:00
FinancialsConservativeSmall CapMomentum Trap

REG-Arix Bioscience PLC Notification of Major Share Holding

============

   Arix Bioscience PLC (ARIX)
   Notification of Major Share Holding

   11-Jan-2022 / 17:04 GMT/BST
   Dissemination of a Regulatory Announcement, transmitted by EQS Group.
   The issuer is solely responsible for the content of this announcement.

   ══════════════════════════════════════════════════════════════════════════

   TR-1: Standard form for notification of major holdings

    

   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to
   the FCA in Microsoft Word format if possible) i
                                                                             
   1a. Identity of the issuer or the
   underlying issuer of existing shares to         ARIX BIOSCIENCE PLC
   which voting rights are attached ii:
   1b. Please indicate if the issuer is a non-UK issuer  (please mark with an
   "X" if appropriate)
   Non-UK issuer                                                           
   2. Reason for the notification (please mark the appropriate box or boxes
   with an "X")
   An acquisition or disposal of voting rights                            X
   An acquisition or disposal of financial instruments                     
   An event changing the breakdown of voting rights                        
   Other (please specify) iii:                                             
   3. Details of person subject to the notification obligation iv
                                            Acacia Research Corporation
   Name
                                             
   City and country of registered office    New York, United States of
   (if applicable)                          America
   4. Full name of shareholder(s) (if different from 3.) v
   Name                                     Merton Acquisition Holdco LLC
                                            New York, United States of
   City and country of registered office    America
   (if applicable)
                                             
   5. Date on which the threshold was       7 January 2022
   crossed or reached vi:
   6. Date on which issuer notified         11 January 2022
   (DD/MM/YYYY):
   7. Total positions of person(s) subject to the notification obligation
                      % of voting     % of voting                Total number
                        rights      rights through    Total of   of voting
                      attached to      financial      both in %  rights held
                     shares (total    instruments    (8.A + 8.B) in issuer
                       of 8. A)    (total of 8.B 1 +             (8.A + 8.B)
                                        8.B 2)                   vii
   Resulting
   situation on the
   date on which     20.541513     0                 20.541513   26535485
   threshold was
   crossed or
   reached
   Position of
   previous
   notification (if  19.05         0                 19.05        

   applicable)
                                                                         

    

   8. Notified details of the resulting situation on the date on which the
   threshold was crossed or reached viii
   A: Voting rights attached to shares
   Class/type of Number of voting rights ix         % of voting rights
   shares
                      Direct           Indirect         Direct      Indirect
   ISIN code (if
   possible)         (DTR5.1)         (DTR5.2.1)       (DTR5.1)    (DTR5.2.1)
   GB00BD04507   26535485          0                20.541513      0
                                                                    
                                                                    
   SUBTOTAL 8. A              26535485                      20.541513
    

    
   B 1: Financial Instruments according to DTR5.3.1R (1) (a)
                                              Number of voting
   Type of                  Exercise/         rights that may be   % of
   financial     Expiration Conversion Period acquired if the      voting
   instrument    date x     xi                instrument is        rights

                                              exercised/converted.
                                                                    
                                                                    
                                                                    
                            SUBTOTAL 8. B 1                         
    

    
   B 2: Financial Instruments with similar economic effect according to
   DTR5.3.1R (1) (b)
   Type of                  Exercise/     Physical or     Number   % of
   financial   Expiration   Conversion    cash            of       voting
   instrument  date x       Period xi                     voting   rights
                                          Settlement xii  rights
                                                                    
                                                                    
                                                                    
                                          SUBTOTAL 8.B.2            
    

    
                                                                    

    

   9. Information in relation to the person subject to the notification
   obligation (please mark the

   applicable box with an "X")
   Person subject to the notification obligation is not controlled by
   any natural person or legal entity and does not control any other      
   undertaking(s) holding directly or indirectly an interest in the
   (underlying) issuer xiii
   Full chain of controlled undertakings through which the voting
   rights and/or the
   financial instruments are effectively held starting with the          x
   ultimate controlling natural person or legal entity (please add
   additional rows as necessary) xiv
                       % of voting      % of voting rights   Total of both if
                       rights if it     through financial    it equals or is
        Name xv        equals or is     instruments if it    higher than the
                     higher than the   equals or is higher      notifiable
                        notifiable     than the notifiable      threshold
                        threshold           threshold
   Acacia Research   20.541513        0                      20.541513
   Corporation
   Merton
   Acquisition       20.541513        0                      20.541513
   Holdco LLC
                                                              
                                                              
                                                              
    
   10. In case of proxy voting, please identify:
   Name of the proxy holder            
   The number and % of voting rights   
   held
   The date until which the voting     
   rights will be held
    
   11. Additional information xvi
   Merton Acquisition Holdco LLC is a wholly-owned subsidiary of Acacia
   Research Corporation.
                                                                       

    

   Place of completion New York, New York, USA
   Date of completion  11 January 2022

    

   ══════════════════════════════════════════════════════════════════════════

   ISIN:          GB00BD045071
   Category Code: HOL
   TIDM:          ARIX
   LEI Code:      213800OVT3AHQCXNIX43
   Sequence No.:  135949
   EQS News ID:   1267530


    
   End of Announcement EQS News Service

   ══════════════════════════════════════════════════════════════════════════

    1 fncls.ssp?fn=show_t_gif&application_id=1267530&application_name=news&site_id=refinitiv

References

   Visible links


============

Recent news on Arix Bioscience

See all news